Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial

Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2, while the study record page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T22:40:59.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:27:01.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The clinical trial record page displays a 403 Forbidden error instead of study details.
    Difference
    0.2%
    Check dated 2026-10-03T22:23:28.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the usual study details with an access-restricted notice. This reflects an access/server issue rather than an update to the study content.
    Difference
    18%
    Check dated 2026-09-19T22:20:56.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Adds a line listing '2018 ( U.S. NIH Grant/Contract )' to the page, signaling the funding source. Updates the page revision to v3.6.6, replacing the previous v3.6.5 as part of a minor metadata update.
    Difference
    0.1%
    Check dated 2026-08-29T19:02:20.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, reflecting a backend/frontend software update. No study content or data changes are reflected in this modification.
    Difference
    0.0%
    Check dated 2026-08-08T16:27:41.000Z thumbnail image

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.